Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

Causas y Mecanismos de Disnea

Mecanismos Fisiopatológicos Principales

  • La disnea resulta de dos mecanismos fisiopatológicos principales: aumento del impulso respiratorio y alteración de la mecánica ventilatoria 1
  • Enfermedad pulmonar intersticial causa disnea por estimulación directa de receptores pulmonares 1, 2
  • Derrame pleural genera compresión y atelectasia que activa receptores mecánicos 1
  • Enfermedad vascular pulmonar estimula receptores vasculares 1
  • Insuficiencia cardíaca congestiva produce congestión pulmonar y edema que activan múltiples receptores 1, 2
  • Hipoxemia aguda por intercambio gaseoso alterado estimula quimiorreceptores 1, 2
  • Hipoxia ambiental activa quimiorreceptores periféricos 1
  • Hipercapnia aguda por aumento del espacio muerto aumenta el impulso ventilatorio 1
  • Acidosis metabólica aumenta el impulso ventilatorio 1
  • Anemia reduce la capacidad de transporte de oxígeno, causando hipoxia tisular incluso con función pulmonar normal 1, 2
  • Hemoglobinopatías disminuyen la liberación de oxígeno a los tejidos 1
  • Gasto cardíaco disminuido limita la entrega de oxígeno a pesar de contenido arterial adecuado 1, 2
  • Embarazo aumenta predominantemente el impulso respiratorio 1
  • Síndrome de hiperventilación, trastornos de ansiedad, ataques de pánico generan disnea por mecanismos centrales 1
  • Asma causa broncoconstricción con sensación característica de "opresión torácica" 1, 3
  • EPOC produce obstrucción crónica e hiperinflación dinámica 1
  • Laringoespasmo obstruye la vía aérea superior 1
  • Aspiración de cuerpo extraño causa obstrucción mecánica aguda 1
  • Bronquitis inflama y estrecha las vías aéreas 1
  • Miastenia gravis afecta la transmisión neuromuscular 1
  • Síndrome de Guillain-Barré causa parálisis ascendente 1
  • Lesión de médula espinal interrumpe la inervación de músculos respiratorios 1
  • Miopatías debilitan directamente los músculos respiratorios 1
  • Síndrome post-poliomielitis produce debilidad muscular tardía 1
  • Cifoescoliosis severa restringe la expansión torácica 1
  • Obesidad aumenta el costo de oxígeno de la respiración sin broncoconstricción 1, 4
  • Derrame pleural limita la expansión pulmonar 1

Características Clínicas Distintivas

  • "Opresión torácica" es relativamente específica de broncoconstricción (asma) 1, 3, 4
  • "Hambre de aire" e "incapacidad para respirar profundo" caracterizan hiperinflación dinámica (EPOC) y mecánica restrictiva (insuficiencia cardíaca, fibrosis pulmonar) 1, 3, 5
  • Sensaciones de esfuerzo, sofocación y respiración rápida son inespecíficas pero pueden indicar ataques de pánico 1, 3

Enfoque Diagnóstico Algorítmico

  • Historia clínica y examen físico son fundamentales y establecen el diagnóstico en 66% de los casos 1, 6
  • Buscar específicamente: uso de músculos accesorios, distensión venosa yugular, disminución de ruidos respiratorios, sibilancias, frote pleural, acropaquias, paradoja toracoabdominal 1
  • Pruebas de primera línea: radiografía de tórax, electrocardiograma, espirometría, biometría hemática completa, panel metabólico básico, oximetría de pulso 1, 6
  • Referencia especializada identifica causas tratables en pacientes con diagnóstico elusivo 1, 6, 4

Dyspnea with Preserved Lung Capacity

Core Pathophysiological Mechanisms

  • The American Thoracic Society identifies that dyspnea can occur independent of lung capacity due to increased respiratory drive, impaired ventilatory mechanics, cardiovascular dysfunction, neuromuscular weakness, and metabolic derangements 7, 8
  • Anemia reduces oxygen-carrying capacity, triggering compensatory hyperventilation despite normal pulmonary function, as stated by the American Thoracic Society 7
  • Metabolic acidosis stimulates chemoreceptors, increasing ventilatory demand, according to the American Thoracic Society 7
  • Decreased cardiac output limits oxygen delivery to tissues, creating tissue hypoxia even when lungs function normally, as identified by the American Thoracic Society 7
  • Pulmonary vascular disease stimulates vascular receptors and increases dead space ventilation, as stated by the American Thoracic Society 7
  • Heart failure activates pulmonary receptors through interstitial edema and congestion, independent of lung capacity, according to the American Thoracic Society 7
  • Neuromuscular weakness creates a mismatch between respiratory effort and achieved ventilation, as identified by the American Thoracic Society 7
  • Chest wall restriction limits expansion without reducing measured static lung capacity, according to the American Thoracic Society 7

Cardiovascular Causes Masquerading as Respiratory Disease

  • The American Thoracic Society recommends investigating cardiovascular deconditioning and considering pulmonary rehabilitation for chronic exertional dyspnea 9
  • Heart failure with preserved ejection fraction causes dyspnea primarily with activity despite normal lung capacity, as stated by the American Thoracic Society 7

Critical Clinical Caveat

  • Dyspnea predicts mortality more strongly than FEV1 in many conditions, never dismiss symptoms because spirometry is normal, as stated by the American Thoracic Society 10, 8

Dyspnea with Preserved Lung Capacity: Mechanisms and Approach

Core Pathophysiological Mechanisms

  • The American Thoracic Society emphasizes that dyspnea results from multiple mechanisms beyond simple lung volume measurements, including increased respiratory drive, cardiovascular dysfunction, metabolic derangements, neuromuscular weakness, and altered central processing, which can produce severe symptoms without reduced lung capacity 11

Diagnostic Approach and Treatment

  • The American Thoracic Society found that dyspnea is more closely correlated with 5-year survival than forced expiratory volume in some patient populations, and dyspnea predicts mortality more strongly than FEV₁ in chronic lung disease 11
  • The American Thoracic Society recommends investigating cardiovascular deconditioning and considering pulmonary rehabilitation for chronic exertional dyspnea with reduced functional capacity, even when lung function is preserved 11
  • B-natriuretic peptide (BNP) has diagnostic utility for heart failure in the appropriate clinical setting, according to the American Journal of Respiratory and Critical Care Medicine 11, 12
  • Echocardiography is useful to assess cardiac function, particularly heart failure with preserved ejection fraction, as recommended by the Journal of Allergy and Clinical Immunology 12
  • Cardiopulmonary exercise testing (CPET) is the definitive noninvasive tool to differentiate cardiac, pulmonary, vascular, and deconditioning causes when the diagnosis remains elusive, according to the American Journal of Respiratory and Critical Care Medicine 13, 12

Clinical Presentation and Diagnosis

  • Heart failure causes dyspnea through pulmonary congestion and interstitial edema, characterized by symptoms of "air hunger" and "inability to get a deep breath", as described in the American Journal of Respiratory and Critical Care Medicine 14

REFERENCES

2

Mechanisms of Dyspnea [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Dyspnea on Exertion in Rheumatoid Arthritis Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Orthopnea and Related Respiratory Conditions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

12

exercise-induced bronchoconstriction update-2016. [LINK]

Journal of Allergy and Clinical Immunology, 2016

13

ats/accp statement on cardiopulmonary exercise testing. [LINK]

American Journal of Respiratory and Critical Care Medicine, 2003